Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hormonal Mechanisms of Sleep Restriction
NCT04037605Phase 1Active, not recruiting
- Sponsor
- The Lundquist Institute
- Start
- Feb 2020
- Primary completion
- Jul 2022
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial (4 arms), sponsored by The Lundquist Institute. Primary endpoints: Average Blood Cortisol Concentration at 5 days and Average Blood Testosterone Concentration at 5 days. Started Feb 2020; status: active, not recruiting.
Beyond the preview
Go deeper on NCT04037605.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04037605.